|
Re: Armageddon
|
2
|
Copper Fox Metals Inc.
|
Aug 17, 2020 04:07PM
|
|
Re: Armageddon
|
4
|
Copper Fox Metals Inc.
|
Aug 17, 2020 04:27PM
|
|
Re: Armageddon
|
2
|
Copper Fox Metals Inc.
|
Aug 17, 2020 05:08PM
|
|
Re: Arizona Neighbor News
|
7
|
Copper Fox Metals Inc.
|
Sep 01, 2023 06:12PM
|
|
Re: Are the IRR% correct in the VD PEA?
|
9
|
Copper Fox Metals Inc.
|
Jan 21, 2021 09:13AM
|
|
Re: Apropos AGM
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 01:37PM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
8
|
Resverlogix Corp.
|
Apr 21, 2021 06:19PM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
6
|
Resverlogix Corp.
|
Apr 20, 2021 07:14PM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
10
|
Resverlogix Corp.
|
Apr 21, 2021 09:41AM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
5
|
Resverlogix Corp.
|
Apr 21, 2021 10:53AM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
5
|
Resverlogix Corp.
|
Apr 21, 2021 12:56PM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
7
|
Resverlogix Corp.
|
Jan 12, 2021 06:59PM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
9
|
Resverlogix Corp.
|
Mar 18, 2021 09:34AM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
1
|
Resverlogix Corp.
|
Aug 22, 2024 11:05AM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
1
|
Resverlogix Corp.
|
Aug 22, 2024 12:11PM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
5
|
Resverlogix Corp.
|
Aug 20, 2024 09:13AM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
2
|
Resverlogix Corp.
|
Aug 21, 2024 09:36AM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
2
|
Resverlogix Corp.
|
Aug 21, 2024 12:44PM
|
|
Re: Apabetalone inhibits kidney damage in diabetes
|
1
|
Resverlogix Corp.
|
Aug 21, 2024 05:53PM
|
|
Re: Apabetalone for Pulmonary Arterial Hypertension (APPROACH-2).
|
6
|
Resverlogix Corp.
|
Aug 24, 2021 02:53PM
|
